🇺🇸 Hectorol in United States

FDA authorised Hectorol on 9 June 1999

Marketing authorisations

FDA — authorised 9 June 1999

  • Marketing authorisation holder: GENZYME CORP
  • Status: approved

FDA — authorised 23 September 2011

  • Application: ANDA091433
  • Marketing authorisation holder: HIKMA
  • Local brand name: DOXERCALCIFEROL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 30 August 2013

  • Application: ANDA091101
  • Marketing authorisation holder: HIKMA
  • Local brand name: DOXERCALCIFEROL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 4 February 2014

  • Application: ANDA200926
  • Marketing authorisation holder: CAPLIN
  • Local brand name: DOXERCALCIFEROL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 7 May 2015

  • Application: ANDA203929
  • Marketing authorisation holder: EPIC PHARMA LLC
  • Local brand name: DOXERCALCIFEROL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 9 September 2016

  • Application: ANDA201518
  • Marketing authorisation holder: RISING
  • Local brand name: DOXERCALCIFEROL
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 24 May 2017

  • Application: ANDA208975
  • Marketing authorisation holder: AMNEAL
  • Local brand name: DOXERCALCIFEROL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 24 May 2017

  • Application: ANDA208974
  • Marketing authorisation holder: AMNEAL
  • Local brand name: DOXERCALCIFEROL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 1 November 2018

  • Application: ANDA210801
  • Marketing authorisation holder: LUPIN
  • Local brand name: DOXERCALCIFEROL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 26 September 2019

  • Application: ANDA210452
  • Marketing authorisation holder: GLAND
  • Local brand name: DOXERCALCIFEROL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 7 February 2020

  • Application: ANDA211670
  • Marketing authorisation holder: MEITHEAL
  • Local brand name: DOXERCALCIFEROL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

Hectorol in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in United States

Frequently asked questions

Is Hectorol approved in United States?

Yes. FDA authorised it on 9 June 1999; FDA authorised it on 23 September 2011; FDA authorised it on 30 August 2013.

Who is the marketing authorisation holder for Hectorol in United States?

GENZYME CORP holds the US marketing authorisation.